Higher thoracic radiation dose is beneficial in patients with extensive small cell lung cancer
Radiation Oncology Journal. 2019;37(3):185-192 
Extensive Disease Small Cell Lung Cancer Dose-Response Relationships: Implications for Resistance Mechanisms: Erratum
Journal of Thoracic Oncology. 2011;6(7):1281
Standard vs. Higher-Dose Consolidative Thoracic Radiation in Extensive-Stage Small Cell Lung Cancer
International Journal of Radiation Oncology*Biology*Physics. 2021;111(3):e464-e465
Thoracic radiotherapy for extensive-stage small-cell lung cancer: what is the optimal dose and timing?
Journal of Radiation Oncology. 2019;8(3):251-258
Practice Patterns of Thoracic Radiotherapy for Extensive-Stage Small-Cell Lung Cancer: Survey of US Academic Thoracic Radiation Oncologists
Clinical Lung Cancer. 2017;18(3):310-315.e1
Randomized phase II trial of high-dose 4′-epi-doxorubicin + cyclophosphamide versus high-dose 4′-epi-doxorubicin + cisplatin in previously untreated patients with extensive small cell lung cancer
Lung Cancer. 1993;10(1-2):147
Current patterns of care for patients with extensive stage small cell lung cancer: Survey of US radiation oncologists on their recommendations regarding thoracic consolidation radiotherapy
Lung Cancer. 2016;100:85-89
The Importance of Thoracic Radiation Therapy and Radiation Dose on the Prognosis of Extensive-Stage Small Cell Lung Cancer
International Journal of Radiation Oncology*Biology*Physics. 2016;96(2):E437
Randomized trial of high vs. standard dose VP16/cisplatin in extensive Small Cell Lung Cancer (SCLC)
Lung Cancer. 1991;7:135
P2.05-016 Higher Dose of Radiotherapy Better for Outcome of Patients with Locally Advanced Non-Small Cell Lung Cancer
Journal of Thoracic Oncology. 2017;12(1):S1040